Spectranetics releases new lead locking device
Spectranetics has released its LLD EZ lead locking device (LLD) for the removal of non-functional or infected pacing and defibrillation leads, which allows physicians to secure the entire lead creating traction to enable the removal process.
The company said its LLD EZ provides a flexible solution to address the removal of leads from scar tissue holding them in place. LLD EZ employs a braided mesh that expands to secure leads along their hollow inner lumen permitting physicians to apply steady traction on the lead. The locking mechanism can be reversed, or unlocked, if the physician needs to remove the device from the lead or reposition it, according to the Colorado Springs, Colo.-based Spectranetics.
“Controlling the entire lead length throughout the removal process is important for achieving safe and complete removal,” said Laurence Epstein, MD, chief of cardiac arrhythmia services at Brigham and Women’s Hospital in Boston.
LLD EZ also features an enhanced tip design and sleek profile to facilitate tracking and passage of the device through tight curves and beyond lumen damage, the company said.
The company said its LLD EZ provides a flexible solution to address the removal of leads from scar tissue holding them in place. LLD EZ employs a braided mesh that expands to secure leads along their hollow inner lumen permitting physicians to apply steady traction on the lead. The locking mechanism can be reversed, or unlocked, if the physician needs to remove the device from the lead or reposition it, according to the Colorado Springs, Colo.-based Spectranetics.
“Controlling the entire lead length throughout the removal process is important for achieving safe and complete removal,” said Laurence Epstein, MD, chief of cardiac arrhythmia services at Brigham and Women’s Hospital in Boston.
LLD EZ also features an enhanced tip design and sleek profile to facilitate tracking and passage of the device through tight curves and beyond lumen damage, the company said.